Immunity to schistosomes.
Significant advances have been made during the past years in our knowledge of schistosomiasis, the second major parasitic disease in the world. The highlights provide a good illustration of the recent progress made in our understanding of immunity in human populations and the regulation of the immune response, and in the approach toward a vaccine.
Capron
A R
AR
Centre d'Immunologie et de Biologie Parasitaire, Unité Mixte INSERM U167-CNRS 624, Institut Pasteur, Lille, France.
D000818:Animals; D000909:Antibodies, Helminth / Q000276:immunology; D000947:Antigens, Helminth / Q000276:immunology; D016207:Cytokines / Q000276:immunology; D006790:Host-Parasite Interactions / Q000276:immunology; D006801:Humans; D007109:Immunity; D012550:Schistosoma mansoni / Q000276:immunology*; D012555:Schistosomiasis mansoni / Q000276:immunology*; D016176:T-Lymphocyte Subsets / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology
D000909:Antibodies, Helminth; D000947:Antigens, Helminth; D016207:Cytokines; D014614:Vaccines, Synthetic